Table 2 Vorinostat inhibits proliferation of a variety of transformed cells in vitro

From: Cancer biology: mechanism of antitumour action of vorinostat (suberoylanilide hydroxamic acid), a novel histone deacetylase inhibitor

Lymphoma

Breast adenocarcinoma

Myeloma

Pancreatic cancer

Leukaemia

Glioblastoma

Mesothelioma

Prostate cancer

Non-small cell lung carcinoma

Ovarian cancer

Bladder carcinoma

Melanoma

Colon carcinoma

Renal cell carcinoma

Thyroid cancer

Endometrial cancer

Back to article page